Search
-
Pharma knocks tech off the top spot as most trusted industry in Ipsos' latest global report on Trust
Business leaders are not trusted to tell the truth – yet are seen to have a responsibility to speak out on issues according to the new Ipsos Global Trustworthiness Monitor report.
-
Ipsos Update – January 2023
Inclusivity, climate change, broken-system sentiment… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos around the world.
-
Gen Z: grounds for optimism?
Are there grounds for optimism about Britain’s youngest generation, and what might this mean for government and labour market? Data suggests that despite the pandemic, inflation, and war, the British public’s optimism for today’s youth has risen gently. Generational analysis suggests the youngest cohort, Generation Z, feels a little less pessimistic about their economic situation compared with Millennials when they were a similar age. But are they really a more optimistic group or just a reversion to the mean after the Millennials’ tough experience entering adulthood in the shadow of the 2008 economic crash?
-
Harsh home truths
Economic turmoil has brought the housing affordability crisis into sharper relief for mortgage holders and renters. What can Government do? The response to COVID-19 was to pull more levers: eviction bans, mortgage and Stamp Duty holidays. In the Autumn Statement, Chancellor Jeremy Hunt announced capping social rents in England, but the Scottish Government had already gone further, faster, introducing a freeze on private as well as social rents and a moratorium on evictions. Previously, Michael Gove recommitted the Government to building 300,000 homes a year. Action will take years to deliver results, requiring considerable political courage. Public opinion will need careful management too. Has the housing crisis become bigger and uglier?
-
Understanding Society 2022: What is the real cost of the cost of living crisis?
This edition of Understanding Society covers a diverse and varied array of topics relating to the cost-of-living crisis, and how the rising costs have been affecting British society. Ipsos researchers consider food insecurity, sustainable living, the housing market, generational divides, and much more.
-
Mission critical – Levelling Up, a balancing act
Prime Minister Rishi Sunak gave a ‘cast-iron commitment’ to prioritise levelling up in his first PMQs. In the face of an economic situation requiring ‘eye-wateringly difficult decisions’, what hope do the public have that living standards, high streets, and public services will prosper in the coming years? The public are pessimistic about delivery but the appetite for action is unlikely to lessen.
-
From the cost of living to sustainable living
A greener lifestyle is often seen as expensive but is the cost of living crisis changing this? Our research shows that UK households plan to make environmentally friendly changes due to, not despite of, the rising costs. These changes create opportunities to tackle two key concerns together and the public don't always see a trade-off. How can Government and businesses make the most of this and change the narrative to “it is cheap being green”? And what are the implications for encouraging sustainable behaviour change?
-
An economist's take: Interview with Dr Linda Yueh
Through an economist's lens, Dr Linda Yueh shares her take on key challenges of the cost of living crisis, thoughts on economic policy and growth, and some possible glimmers of good news.
Dr Linda Yueh is an economist at Oxford University and London Business School, and the author of The Great Economists: How Their Ideas Can Help Us Today. -
Multi-source Data to Insights - How to navigate the new reality for Pharma
Over the last few years there has been huge growth in the availability of digital data sources and health data.
-
Improvement seen in research-based pharma industry reputation
Research by Ipsos commissioned by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) shows an improvement in research-based pharmaceutical industry reputation, with people valuing pharma innovation and the benefits it brings to society.